R. Skoda, A. Duek, and J. Grisouard, Pathogenesis of myeloproliferative neoplasms, Experimental Hematology, vol.43, issue.8, pp.599-608, 2015.
DOI : 10.1016/j.exphem.2015.06.007

S. Hermouet, A. Godard, and D. Pineau, ABNORMAL PRODUCTION OF INTERLEUKIN (IL)-11 AND IL-8 IN POLYCYTHAEMIA VERA, Cytokine, vol.20, issue.4, pp.178-183, 2002.
DOI : 10.1006/cyto.2002.1994

M. Boissinot, C. Cleyrat, and M. Vilaine, Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F, Oncogene, vol.82, issue.8, pp.990-1001, 2011.
DOI : 10.1007/s00005-008-0022-5

A. Tefferi, R. Vaidya, and D. Caramazza, Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study, Journal of Clinical Oncology, vol.29, issue.10, pp.1356-1363, 2011.
DOI : 10.1200/JCO.2010.32.9490

E. Pourcelot, C. Trocme, and J. Mondet, Cytokine profiles in polycythemia vera and essential thrombocythemia patients: Clinical implications, Experimental Hematology, vol.42, issue.5, pp.360-368, 2014.
DOI : 10.1016/j.exphem.2014.01.006

URL : https://hal.archives-ouvertes.fr/hal-00949162

H. Hasselbalch, Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?, Leukemia Research, vol.37, issue.2, pp.214-220, 2013.
DOI : 10.1016/j.leukres.2012.10.020

N. Pemmaraju, H. Kantarjian, and T. Kadia, A Phase I/II Study of the Janus Kinase (JAK)1 and 2 Inhibitor Ruxolitinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia, Clinical Lymphoma Myeloma and Leukemia, vol.15, issue.3, pp.171-176, 2015.
DOI : 10.1016/j.clml.2014.08.003

L. Bousse-kerdil-es and M. , Primary myelofibrosis and the ''bad seeds in bad soil'' concept, Fibrogenesis Tissue Repair, vol.5, p.20, 2012.

A. Fleischman, K. Aichberger, and S. Luty, TNF?? facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms, Blood, vol.118, issue.24, pp.6392-6398, 2011.
DOI : 10.1182/blood-2011-04-348144

B. Mager, C. Riether, and C. Schurch, IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms, Journal of Clinical Investigation, vol.125, issue.7, pp.2579-2591, 2015.
DOI : 10.1172/JCI77347DS1